PREFERENCE OF WOMEN WITH FIBROMYALGIA UNDERGOING THREE DIFFERENT VOLUMES OF RESISTANCE TRAINING: CROSSOVER RANDOMIZED CLINICAL TRIAL
Fibromyalgia, Resistance training, Training volume.
Fibromyalgia is a painful syndrome of unknown etiology, which affects 2% of the world's population, with some symptoms such as: pain, unrefreshing sleep, fatigue and mood disorders. It is already established in the literature that resistance training is part of the non-pharmacological treatment for patients with fibromyalgia. The big question is what is the appropriate and/or recommended amount of exercise for this patient, although some studies with different resistance training volumes show improvements, we do not have a guideline, and we do not yet know if there is a preference for some of these patients. in different volumes of resistance training. Objective: Assess the preference of the volume of resistance training in women with fibromyalgia. Methods: Crossover, randomized and blind clinical trial. 36 women with fibromyalgia will be evaluated,
who will be subjected to three resistance training programs with different training volumes. The primary outcome will be the patient's preference in relation to training volumes, and the secondary outcomes will be: patient expectation, pain intensity, affection and
subjective perception of effort. Statistical analysis: For the primary outcome preference, the number of choices of the 3 types of training will be counted as a percentage.
Regarding the analysis of the primary outcome, we will summarize the patient's preference in a contingency table, compare the proportions using the Chi-square test, and finally
we will check the effect size of the observed differences. For secondary outcomes, statistical analyzes will be performed by a blinded statistician using commercial software.
The Kolmogorov–Smirnov test will be applied to verify the distribution of the data and the Levene test will be used to analyze the homogeneity of variance. The Bonferroni test will be used in post hoc analyzes to determine whether there are differences between the
groups at different intervention times. A significance level of 5% and 95% CI will be adopted for all statistical analyses. Ethics and disclosure: This protocol will be submitted to the UFRN/FACISA Ethics Committee. Study results will be disseminated to participants and submitted to a peer-reviewed journal and scientific meetings.